We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

002302:SZSEChina West Construction Group Co., Ltd Analysis

Data as of 2026-03-12 - not real-time

CN¥6.49

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

China West Construction is trading at CNY 6.49, modestly above its 20‑day (6.38) and 50‑day (6.25) simple moving averages and just over the 200‑day average (6.41), indicating short‑term momentum but a neutral longer‑term trend. Technical signals are mixed: the RSI sits at 55, the MACD histogram is positive (bullish signal) and the price is perched between a clear support at 6.00 and resistance near 6.77, while volume has been decreasing and 30‑day volatility is high at ~39.6%. Fundamentally, the company faces challenges: trailing EPS is –0.39, revenue fell 5.1% YoY, and operating margins are negative, yet free cash flow remains positive (~CNY 0.60 bn) and the dividend yield is 1.91% with a 53% payout ratio. The forward PE of 54 is steep, the DCF‑derived fair value (5.55) lies well below the current price, and the price‑to‑book ratio (0.96) suggests a slight discount to book but not enough to offset valuation concerns. Debt‑to‑equity is modest at 31.5% and beta is extremely low (≈0.06), implying limited market‑wide price swings but the stock’s high volatility reflects company‑specific risks. Overall, the market appears to be pricing in a potential earnings turnaround, but the current valuation appears stretched relative to intrinsic estimates and cash‑flow fundamentals.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near resistance with decreasing volume
  • Bullish MACD but high short‑term volatility
  • Negative earnings and high forward PE

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Potential earnings recovery reflected in forward EPS
  • Sustained free cash flow supporting dividend
  • Valuation still above DCF fair value

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Low beta and solid balance sheet with manageable debt
  • Discount to book value and stable dividend yield
  • Opportunity for price correction toward intrinsic DCF value

Key Metrics & Analysis

Financial Health

Revenue Growth-5.10%
Profit Margin-2.45%
P/E Ratio54.1
ROE-4.37%
ROA-0.51%
Debt/Equity31.51
P/B Ratio1.0
Op. Cash FlowCN¥449.9M
Free Cash FlowCN¥604.5M

Technical Analysis

TrendNeutral
RSI55.5
SupportCN¥6.00
ResistanceCN¥6.77
MA 20CN¥6.38
MA 50CN¥6.25
MA 200CN¥6.41
MACDBullish
VolumeDecreasing
Fear & Greed Index75.14

Valuation

Fair ValueCN¥5.55
GradeOvervalued
TypeValue
Dividend Yield1.91%

Risk Assessment

Beta0.06
Volatility39.58%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.